What is the active ingredient in Unisom (doxylamine)

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The active ingredient in Unisom SleepTabs is doxylamine succinate, while Unisom SleepGels contain diphenhydramine hydrochloride. The original Unisom SleepTabs contain doxylamine succinate (25mg), which is an antihistamine that causes drowsiness by blocking histamine receptors in the brain. However, Unisom SleepGels contain diphenhydramine hydrochloride (50mg), another antihistamine that works similarly. Both ingredients are effective for short-term treatment of insomnia, typically helping you fall asleep about 30 minutes after taking them. These medications work by reducing brain activity and blocking signals that keep you awake. Side effects may include dry mouth, dizziness, and morning grogginess. It's essential to use these sleep aids only for short periods (generally less than two weeks) as they can lose effectiveness over time and aren't intended for treating chronic insomnia, as suggested by 1. If you're pregnant, diphenhydramine is generally considered safer than doxylamine, though you should always consult with a healthcare provider before taking any medication during pregnancy. Some key considerations for the use of these medications include:

  • Potential for sedation, performance impairment, and anticholinergic effects, as noted in 1
  • Importance of using the lowest effective dose and for the shortest duration necessary, as recommended in 1
  • Need for caution in older adults and those with comorbid conditions, as advised in 1
  • Availability of alternative treatments, such as cognitive behavioral therapy for insomnia, as discussed in 1

From the FDA Drug Label

Active ingredient (in each tablet) Doxylamine succinate 25 mg The active ingredient in Unisom (doxylamine) is Doxylamine succinate. Key points:

  • The active ingredient is Doxylamine succinate
  • The dosage is 25 mg per tablet 2

From the Research

Active Ingredient in Unisom

  • The active ingredient in Unisom is doxylamine, which is an antihistamine of the ethanolamine class 3.
  • Doxylamine is used primarily as a sleep-inducing agent and is available without a prescription in some countries, including the Federal Republic of Germany 3.
  • Doxylamine succinate is the chemically defined active ingredient in some sleeping medications, including Unisom 4, 5, 6.

Pharmacokinetics and Pharmacodynamics

  • The pharmacokinetics and pharmacodynamics of doxylamine have been studied in various clinical trials, including a Phase I study of intranasal doxylamine in subjects with chronic intermittent sleep impairment 4.
  • The study found that doxylamine pharmacokinetics were similar between intranasal and oral dosing, with no significant differences in maximum plasma concentration or area under the curve 4.
  • Another study found that food intake did not affect the pharmacokinetics of doxylamine in healthy subjects 5.

Availability and Use

  • Doxylamine is available over-the-counter (OTC) in various formulations, including tablets and nasal sprays 4, 6.
  • It is commonly used for the short-term management of insomnia and is also used in combination with other ingredients in OTC sinonasal products 6, 7.
  • Doxylamine has been suggested as a potential treatment for maintenance insomnia, particularly in the last third of the night 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.